rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Grace Wong-Sarad

Principal Accounting Officer

Company insider

Files Form 4 as: Principal Accounting Officer, Alector.

Every Form 4 they filed

In numbers

Trades disclosed
41
Buys
0
Sells
13
Bought
$0
Sold
$198K
Companies
1
Companies where not an officer
0
First trade
2 Sep 2025
Last trade
14 Oct 2026
Last filed
15 Oct 2026

Companies traded

Where they are an officer
ALEC AlectorOfficer · Biotechnology · last 14 Oct 20260 buys · 13 sells

Activity over time

1 Sep 2025 – 1 Oct 2026
30Sep 25Dec 25Apr 26Jul 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
14 Oct 2026filed 15 Oct 2026ALEC AlectorBiotechnologySEC FORM 4 Code A—55,555 at $0.00filing
14 Oct 2026filed 15 Oct 2026ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code A—83,435 at $0.00filing
13 Oct 2026filed 15 Oct 2026ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code D—11,552filing
13 Oct 2026filed 15 Oct 2026ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code A—11,552filing
13 Oct 2026filed 15 Oct 2026ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code D—11,309filing
13 Oct 2026filed 15 Oct 2026ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code A—11,309filing
13 Oct 2026filed 15 Oct 2026ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code D—20,000filing
13 Oct 2026filed 15 Oct 2026ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code A—20,000filing
13 Oct 2026filed 15 Oct 2026ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code D—13,842filing
13 Oct 2026filed 15 Oct 2026ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code A—13,842filing
13 Oct 2026filed 15 Oct 2026ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code D—20,454filing
13 Oct 2026filed 15 Oct 2026ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code A—20,454filing
13 Oct 2026filed 15 Oct 2026ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code D—10,228filing
13 Oct 2026filed 15 Oct 2026ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code A—10,228filing
4 Sep 2026filed 4 Sep 2026ALEC AlectorBiotechnologySEC FORM 4 Sold$9,0943,625 at $2.51filing
4 Sep 2026filed 4 Sep 2026ALEC AlectorBiotechnologySEC FORM 4 Sold$9,0993,625 at $2.51filing
3 Sep 2026filed 4 Sep 2026ALEC AlectorBiotechnologySEC FORM 4 Sold$14K5,165 at $2.67filing
3 Sep 2026filed 4 Sep 2026ALEC AlectorBiotechnologySEC FORM 4 Sold$14K5,165 at $2.67filing
2 Sep 2026filed 4 Sep 2026ALEC AlectorBiotechnologySEC FORM 4 Sold$1,804656 at $2.75filing
2 Sep 2026filed 4 Sep 2026ALEC AlectorBiotechnologySEC FORM 4 Sold$1,804656 at $2.75filing

Sectors

Health Care13

Buys in green, sells in red, by the company’s sector.

Related people

Arnon RosenthalChief Executive Officer · Chief Executive Officer at Alector, filing Form 4 there in the last year
Neil Lindsay BerkleyCFO & Chief Business Officer · CFO & Chief Business Officer at Alector, filing Form 4 there in the last year
Richard H. SchellerDirector · Director at Alector, filing Form 4 there in the last year
Mark AltmeyerDirector · Director at Alector, filing Form 4 there in the last year
Errol B. DesouzaDirector · Director at Alector, filing Form 4 there in the last year